The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II study of WT1 peptide vaccine plus gemcitabine for advanced pancreatic ductal adenocarcinoma (PDAC): Clinical efficacy and immune response.
 
Sumiyuki Nishida
Research Funding - Kyowa Hakko Kirin (Inst); Teijin Pharma (Inst)
 
Takeshi Ishikawa
Research Funding - Takara Bio
 
Satoshi Kokura
No Relationships to Disclose
 
Shinichi Egawa
No Relationships to Disclose
 
Shigeo Koido
No Relationships to Disclose
 
Hiroaki Yasuda
No Relationships to Disclose
 
Hiroaki Yanagimoto
No Relationships to Disclose
 
Jun Ishii
No Relationships to Disclose
 
Yoshihide Kanno
No Relationships to Disclose
 
Mari Saito Oba
Research Funding - Bristol-Myers Squibb (I); MSD (I); Ono Pharmaceutical (I); Takeda; Yakult Pharmaceutical
 
Maho Sato
No Relationships to Disclose
 
Soyoko Morimoto
No Relationships to Disclose
 
Hidetoshi Eguchi
No Relationships to Disclose
 
Hiroaki Nagano
No Relationships to Disclose
 
Sadamu Homma
No Relationships to Disclose
 
Yoshihiro Oka
Research Funding - Kyowa Hakko Kirin (Inst); Otsuka (Inst)
 
Satoshi Morita
No Relationships to Disclose
 
Haruo Sugiyama
Consulting or Advisory Role - Dainippon Sumitomo Pharma
Research Funding - Otsuka (Inst)